The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Open accessAbstract
Nonadherence with medication occurs in all chronic medical disorders. It is a particular challenge in schizophrenia due to the illness's association with social isolation, stigma, and comorbid substance misuse, plus the effect of symptom domains on adherence, including positive and negative symptoms, lack of insight, depression, and cognitive impairment. Nonadherence lies on a spectrum, is often covert, and is underestimated by clinicians, but affects more than one third of patients with schizophrenia per annum. It increases the risk of relapse, rehospitalization, and self-harm, increases inpatient costs, and lowers quality of life. It results from multiple patient, clinician, illness, medication, and service factors, but a useful distinction is between intentional and unintentional nonadherence. There is no gold standard approach to the measurement of adherence as all methods have pros and cons. Interventions to improve adherence include psychoeducation and other psychosocial interventions, antipsychotic long-acting injections, electronic reminders, service-based interventions, and financial incentives. These overlap, all have some evidence of effectiveness, and the intervention adopted should be tailored to the individual. Psychosocial interventions that utilize combined approaches seem more effective than unidimensional approaches. There is increasing interest in electronic reminders and monitoring systems to enhance adherence, eg, Short Message Service text messaging and real-time medication monitoring linked to smart pill containers or an electronic ingestible event marker. Financial incentives to enhance antipsychotic adherence raise ethical issues, and their place in practice remains unclear. Simple pragmatic strategies to improve medication adherence include shared decision-making, regular assessment of adherence, simplification of the medication regimen, ensuring that treatment is effective and that side effects are managed, and promoting a positive therapeutic alliance and good communication between the clinician and patient. These elements remain essential for all patients, not least for the small minority where vulnerability and risk issue dictate that compulsory treatment is necessary to ensure adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · cited 1×
“91 However, weaknesses in the evidence base mean that the relative risk of certain side effects is unclear for some antipsychotic drugs.”
Adherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
Physician Communication and Patient Adherence to Treatment: A Meta-Analysis
Haskard Zolnierek, K. B., & DiMatteo, M. R. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819a5acc · Cited by 2,489
What is Motivational Interviewing?
Rollnick, S., & Miller, W. R. (1995) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246580001643x · Cited by 1,737
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383 · cited 3×
“The association between side effects and nonadherence is complex.(27,54) RCTs often report “dropouts” due to side effects or adverse effects, but individual perceptions or beliefs about the illness or the treatments are not recorded.”
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327
Ten Things that Motivational Interviewing Is Not
Miller, W. R., & Rollnick, S. (2009) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465809005128 · Cited by 1,315
Hogan, T. P., Awad, A. G., & Eastwood, R. (1983) · Psychological Medicine · doi:10.1017/s0033291700050182 · Cited by 1,028
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 957
Confidence intervals for the number needed to treat.
Altman, D. G. (1998) · BMJ · doi:10.1136/bmj.317.7168.1309 · Cited by 938
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931 · cited 3×
“In the maintenance meta-analysis by Leucht et al, weight gain, sedation, and movement disorders were more common in those treated with antipsychotic medication than in those treated with placebo (Figure 1).(11) Antipsychotic-induced weight gain,(15) metabolic disturbance,(16) and hyperprolactinemia(17) are particularl…”
InfluentialHogarty, G. E. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070019003 · Cited by 917
Compliance With Medication Regimens for Mental and Physical Disorders
Cramer, J. A., & Rosenheck, R. (1998) · Psychiatric Services · doi:10.1176/ps.49.2.196 · Cited by 725
Nunes, V. M. D. A., Neilson, J., O’Flynn, N., Calvert, N., Kuntze, S., Smithson, H., Benson, J., Blair, J., Bowser, A., Clyne, W., et al. (2009) · University of Huddersfield Repository (University of Huddersfield) · Cited by 697
Self-citationNatural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033315 · Cited by 649
Autonomous regulation and long-term medication adherence in adult outpatients.
Williams, G. C., Rodin, G. C., Ryan, R. M., Grolnick, W. S., & Deci, E. L. (1998) · Health Psychology · doi:10.1037//0278-6133.17.3.269 · Cited by 641
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625
Self-citationWeiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
Falloon, I. R. H. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320059008 · Cited by 586
Psychoeducation for schizophrenia
Xia, J., Merinder, L. B., & Belgamwar, M. R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002831.pub2 · Cited by 585
Randomised controlled trial of compliance therapy: 18-month follow-up
Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.5.413 · Cited by 520
Hogarty, G. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280056008 · Cited by 504
Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002136 · Cited by 489
Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0317 · Cited by 485
Tarrier, N., Barrowclough, C., Vaughn, C., Bamrah, J. S., Porceddu, K., Watts, S., & Freeman, H. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.153.4.532 · Cited by 464
Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 456
Self-citationVervloet, M., Linn, A. J., van Weert, J. C. M., de Bakker, D. H., Bouvy, M. L., & van Dijk, L. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000748 · Cited by 455
Novick, D., Haro, J. M., Suarez, D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.004 · Cited by 447
Self-citationDay, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A., Cattell, D., Healy, D., Rae, P., & Power, C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.717 · Cited by 360
Community treatment orders for patients with psychosis (OCTET): a randomised controlled trial
Burns, T., Rugkåsa, J., Molodynski, A., Dawson, J., Yeeles, K., Vazquez-Montes, M., Voysey, M., Sinclair, J., & Priebe, S. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60107-5 · Cited by 347
Family-Based Intervention for Schizophrenic Patients in China: A Randomised Controlled Trial
Xiong, W., Phillips, M. R., Hu, X., Wang, R., Dai, Q., Kleinman, J., & Kleinman, A. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.2.239 · Cited by 341
Swartz, M. S., Swanson, J. W., Wagner, H. R., Burns, B. J., Hiday, V. A., & Borum, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1968 · Cited by 340
Should we pay the patient? Review of financial incentives to enhance patient compliance
Giuffrida, A., & Torgerson, D. J. (1997) · BMJ · doi:10.1136/bmj.315.7110.703 · Cited by 337
A systematic review of longitudinal outcome studies of first-episode psychosis
MENEZES, N. M., ARENOVICH, T., & ZIPURSKY, R. B. (2006) · Psychological Medicine · doi:10.1017/s0033291706007951 · Cited by 333
Assessing the New York City involuntary outpatient commitment pilot program
Steadman, H. J., Gounis, K., Dennis, D., Hopper, K., Roche, B., Swartz, M., & Robbins, P. C. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.3.330 · Cited by 312
van Haren, N. E. M., Hulshoff Pol, H. E., Schnack, H. G., Cahn, W., Mandl, R. C. W., Collins, D. L., Evans, A. C., & Kahn, R. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301347 · Cited by 311
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Velligan, D. I., Lam, Y.-W. F., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., & Miller, A. L. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj075 · Cited by 309
Davies, M. J., Gagliardino, J. J., Gray, L. J., Khunti, K., Mohan, V., & Hughes, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12128 · Cited by 294
Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., Golks, D., & Naber, D. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.06.031 · Cited by 267
Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications
Velligan, D. I., Wang, M., Diamond, P., Glahn, D. C., Castillo, D., Bendle, S., Lam, Y. W. F., Ereshefsky, L., & Miller, A. L. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.9.1187 · Cited by 249
Valenstein, M., Ganoczy, D., McCarthy, J. F., Kim, H. M., Lee, T. A., & Blow, F. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1008 · Cited by 238
Interventions to Improve Antipsychotic Medication Adherence: Review of Recent Literature
Dolder, C. R., Lacro, J. P., Leckband, S., & Jeste, D. V. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085413.08426.41 · Cited by 236
Metabolic syndrome and mental illness.
Newcomer, J. W. (2007) · PubMed · Cited by 235
Technique for training schizophrenic patients in illness self- management: a controlled trial
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.11.1549 · Cited by 234
Agid, O., Arenovich, T., Sajeev, G., Zipursky, R. B., Kapur, S., Foussias, G., & Remington, G. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05785yel · Cited by 224
Psychoeducation for schizophrenia
Pekkala, E. T., & Merinder, L. B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002831 · Cited by 223
Compliance therapy: a randomised controlled trial in schizophrenia
O'Donnell, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., Harries, R., Kinsella, A., Larkin, C., & O'Callaghan, E. (2003) · BMJ · doi:10.1136/bmj.327.7419.834 · Cited by 219
Vervloet, M., van Dijk, L., Santen-Reestman, J., van Vlijmen, B., van Wingerden, P., Bouvy, M. L., & de Bakker, D. H. (2012) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2012.05.005 · Cited by 215
Lieberman, J. A., Koreen, A., Chakos, M., Sheitman, B., Woerner, M. G., Alvir, J. M. J., & Bilder, R. M. (1996) · PubMed · Cited by 211
International experiences of using community treatment orders: (622832007-001)
Churchill, R., Owen, G., Singh, S., & Hotopf, M. (2006) · PsycEXTRA Dataset · doi:10.1037/e622832007-001 · Cited by 204
Sun, S. X., Liu, G. G., Christensen, D. B., & Fu, A. Z. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226050 · Cited by 196
Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis
Lemstra, M., Blackburn, D., Crawley, A., & Fung, R. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.007 · Cited by 194
Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial
Gray, R., Leese, M., Bindman, J., Becker, T., Burti, L., David, A., Gournay, K., Kikkert, M., Koeter, M., Puschner, B., et al. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.019489 · Cited by 190
The Natural Course of Schizophrenia: A Review of First-admission Studies
Ram, R., Bromet, E. J., Eaton, W. W., Pato, C., & Schwartz, J. E. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.2.185 · Cited by 189
Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T., Magouirk, B., & Rush, A. J. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.11.002 · Cited by 181
Kirson, N. Y., Weiden, P. J., Yermakov, S., Huang, W., Samuelson, T., Offord, S. J., Greenberg, P. E., & Wong, B. J. O. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r08167 · Cited by 174
de Vries, S. T., Keers, J. C., Visser, R., de Zeeuw, D., Haaijer-Ruskamp, F. M., Voorham, J., & Denig, P. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.11.003 · Cited by 168
A new self-rating scale for detecting atypical or second-generation antipsychotic side effects
Waddell, L., & Taylor, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087976 · Cited by 162
A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia
Law, M. R., Soumerai, S. B., Ross‐Degnan, D., & Adams, A. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0107 · Cited by 157
Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study
Caseiro, O., Pérez‐Iglesias, R., Mata, I. F., Martínez‐García, O., Pelayo‐Terán, J. M., Tabarés‐Seisdedos, R., de la Foz, V. O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.001 · Cited by 154
Montes, J. M. G., Medina, E., Gómez-Beneyto, M., & Mauriño, J. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.034 · Cited by 148
Ascher‐Svanum, H., Zhu, B., Faries, D. E., Lacro, J. P., & Dolde, C. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0715 · Cited by 147
Beck, E., Cavelti, M., Kvrgic, S., Kleim, B., & Vauth, R. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.019 · Cited by 145
Jaeger, M., & Wulf Rössler, A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.11.003 · Cited by 144
The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia
McCabe, R., Bullenkamp, J., Hansson, L. I., Lauber, C., Martínez‐Leal, R., Wulf Rössler, A., Salize, H. J., Svensson, B., Torres‐González, F., van den Brink, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036080 · Cited by 144
Substance abuse in patients with schizophrenia
Winklbaur, B., Ebner, N., Sachs, G., Thau, K., & Fischer, G. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.1/bwinklbaur · Cited by 142
Yang, J.-W., Ko, Y., Paik, J., Lee, M., Han, C., Joe, S.-H., Jung, I., Jung, H.-G., & Kim, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.008 · Cited by 138
Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder
GOFF, D. C., Hill, M. B., & Freudenreich, O. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9096su1cc.04 · Cited by 136
Motivational interviewing to improve insight and treatment adherence in schizophrenia.
Rüsch, N., & Corrigan, P. W. (2002) · Psychiatric Rehabilitation Journal · doi:10.2975/26.2002.23.32 · Cited by 136
Löffler, W., Kilian, R., Toumi, M., & Angermeyer, M. C. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-39985 · Cited by 135
ITAREPS: Information Technology Aided Relapse Prevention Programme in Schizophrenia
Španiel, F., Vohlídka, P., Hrdlička, J., Kožený, J., Novák, T., Motlová, L. B., Cermak, J. K., Bednařík, J., Novák, D., & Höschl, C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.005 · Cited by 135
Acosta, F. J., Bosch, E., Sarmiento, G., Juanes, N., Caballero-Hidalgo, A., & Mayans, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.007 · Cited by 134
Enhancing Medication Compliance for People with Serious Mental Illness
Cramer, J. A., & Rosenheck, R. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199901000-00009 · Cited by 128
Fakhoury, W. K. H., Wright, D., & Wallace, M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200105000-00004 · Cited by 127
Rettenbacher, M. A., Hofer, A., Eder, U., Hummer, M., Kemmler, G., Weiss, E. M., & Fleischhacker, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0908 · Cited by 126
Lysaker, P. H., Vohs, J., Hillis, J. D., Kukla, M., Popolo, R., Salvatore, G., & Dimaggio, G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811150 · Cited by 124
Chen, E. Y.-H., Hui, C. L.-M., Dunn, E. L.-W., Miao, M. Y.-K., Yeung, W.-S., Wong, C.-K., Chan, W.-F., & Tang, W.-N. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.020 · Cited by 123
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
Herings, R. M. C., & Erkens, J. A. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.837 · Cited by 119
Detke, H. C., McDonnell, D., Brunner, E., Zhao, F., Sorsaburu, S., Stefaniak, V. J., & Corya, S. A. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-43 · Cited by 118
Determinants of Patient Adherence to an Aerosol Regimen
Rau, J. L. (2005) · Respiratory Care · doi:10.4187/respcare.05501346 · Cited by 118
Takeuchi, H., Suzuki, T., Remington, G., Bies, R. R., Abe, T., Graff‐Guerrero, A., Watanabe, K., Mimura, M., & Uchida, H. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt090 · Cited by 117
From careless consumptives to recalcitrant patients: The historical construction of noncompliance
Lerner, B. H. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00067-1 · Cited by 116
Patel, M., Haddad, P. M., Chaudhry, I. B., McLoughlin, S., & David, A. S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104882 · Cited by 115
Self-citationAntipsychotic long-acting injections: Prescribing practice in the UK
Barnes, T. R. E., Shingleton‐Smith, A., & Paton, C. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s37 · Cited by 114
Priebe, S., Yeeles, K., Bremner, S. A., Lauber, C., Eldridge, S. M., Ashby, D., David, A. S., O’Connell, N., Forrest, A., & Burns, T. (2013) · BMJ · doi:10.1136/bmj.f5847 · Cited by 113
Waddell, L., & Taylor, M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s43 · Cited by 109
Studies in the Home Treatment of Streptococcal Disease
Mohler, D. N., Wallin, D. G., & Dreyfus, E. G. (1955) · New England Journal of Medicine · doi:10.1056/nejm195506302522604 · Cited by 109
Neuroleptic compliance among chronic schizophrenic outpatients: An intervention outcome report.
Boczkowski, J. A., Zeichner, A., & DeSanto, N. (1985) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.53.5.666 · Cited by 108
A systematic review of the effect of community treatment orders on service use
Maughan, D., Molodynski, A., Rugkåsa, J., & Burns, T. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0781-0 · Cited by 106
Psychopharmacology: Perspectives on Medication Adherence and Atypical Antipsychotic Medications
Velligan, D. I., Lam, F., Ereshefsky, L., & Miller, A. L. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.5.665 · Cited by 105
Wilder, C. M., Elbogen, E. B., Moser, L. L., Swanson, J. W., & Swartz, M. S. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.4.380 · Cited by 100
Dickerson, F., Tenhula, W. N., & Green-Paden, L. D. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.026 · Cited by 97
Herttua, K., Tabák, Á. G., Martikainen, P., Vahtera, J., & Mika Kivimaki, B. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht219 · Cited by 97
Historical perspective on antipsychotic long-acting injections
Johnson, D. A. W. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s7 · Cited by 95
Velligan, D., Mintz, J., Maples, N., Xueying, L., Gajewski, S., Carr, H., & Sierra, C. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs116 · Cited by 87
Dilla, T., Ciudad, A., & Álvarez (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s41609 · Cited by 86
Mortimer, A. M., Singh, P., Shepherd, C., & Puthiryackal, J. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.4 · Cited by 85
McCabe, R., Healey, P. G. T., Priebe, S., Lavelle, M., Dodwell, D., Laugharne, R. A., Snell, A., & Bremner, S. A. (2013) · Patient Education and Counseling · doi:10.1016/j.pec.2013.05.015 · Cited by 83
Ward, A. J., Ishak, K. J., Proskorovsky, I., & Caro, J. J. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.002 · Cited by 83
Velligan, D. I., Diamond, P. M., Maples, N. J., Mintz, J., LI, X., Glahn, D. C., & MILLER, A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.005 · Cited by 83
New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
Citrome, L. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811984 · Cited by 82
Kane, J. M., Perlis, R. H., DiCarlo, L. A., Au-Yeung, K., Duong, J., & Petrides, G. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08222 · Cited by 81 · cited 4×
“The feasibility and safety of the system was recently reported in a small study (n=28) of patients with schizophrenia or bipolar disorder over a 4-week period.(81) Because this was a feasibility study, the digital ingestion sensor was embedded in a placebo tablet and the main outcome was the accuracy of the system to…”
InfluentialMorrison, A. P., Hutton, P., Wardle, M., Spencer, H. M., Barratt, S., Brabban, A., Callcott, P., Christodoulides, T., Dudley, R. E. J., French, P., et al. (2011) · Psychological Medicine · doi:10.1017/s0033291711001899 · Cited by 78
Brain, C., Allerby, K., Sameby, B., Quinlan, P. S., Joas, E., Karilampi, U., Lindström, E., Eberhard, J., Burns, T., & Wærn, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.001 · Cited by 70
Self-citationAdverse effects of antipsychotics as outcome measures
Hamer, S., & Haddad, P. M. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s64 · Cited by 70
Self-citationRisk profiles for non‐adherence to antipsychotic medications
McCann, T. V., BOARDMAN, G., Clark, E., & Lu, L. (2008) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2008.01277.x · Cited by 68
Shared decision-making in ongoing outpatient psychiatric treatment
McCabe, R., Khanom, H., Bailey, P., & Priebe, S. (2013) · Patient Education and Counseling · doi:10.1016/j.pec.2012.12.020 · Cited by 65
Peuskens, J., Olivares, J. M., Pečeňák, J., Tuma, I. S. M., de Weg, H. B., Eriksson, L., Resseler, S., Akhras, K. S., Jacobs, A., & on behalf of the e-STAR study group (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903488670 · Cited by 64
Long‐acting injectable antipsychotics in early psychosis: a literature review
Emsley, R., Chiliza, B., Asmal, L., Mashile, M., & Fusar‐Poli, P. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12027 · Cited by 61
Hayhurst, K. P., Drake, R., Massie, J. A., Dunn, G., Barnes, T. R. E., Jones, P. B., & Lewis, S. W. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.03.002 · Cited by 59
Weight Change From 3-Year Observational Data
Bushe, C., Slooff, C. J., Haddad, P. M., & Karagianis, J. L. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07246 · Cited by 58
Self-citationRisk of osteoporosis and fracture incidence in patients on antipsychotic medication
Graham, S. M., Howgate, D. J., Anderson, W. C., Howes, C., Heliotis, M., Mantalaris, A., Tsiridis, E. E., & Tsapakis, E.-M. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.560112 · Cited by 58
Haddad, P. M., Fleischhacker, W. W., Peuskens, J., Cavallaro, R., Lean, M. E. J., Ma, M., Reynolds, G. P., Azorin, J., Thomas, P., & Möller, H. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313510195 · Cited by 57
Self-citationIs antipsychotic medication stigmatizing for people with mental illness?
Sajatovic, M., & JENKINS, J. H. (2007) · International Review of Psychiatry · doi:10.1080/09540260701278911 · Cited by 55
Efficacy of Contingency Management for Cocaine Dependence Treatment: A Review of the Evidence
Schierenberg, A., van Amsterdam, J., van den Brink, W., & Goudriaan, A. E. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205040006 · Cited by 55
Subjective side effects of antipsychotics and medication adherence in people with schizophrenia
McCann, T. V., Clark, E., & Lu, L. (2009) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2008.04906.x · Cited by 48
Liu‐Seifert, H., Osuntokun, O. O., & Feldman, P. D. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.12.003 · Cited by 46
Nakonezny, P. A., Byerly, M., & Rush, A. J. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.05.001 · Cited by 45
Measurement of Adherence to Brimonidine Therapy for Glaucoma Using Electronic Monitoring
Hermann, M. M., Bron, A. M., Garcher, C. C., et al. (2010) · Journal of Glaucoma · doi:10.1097/ijg.0b013e3181f3eb4a · Cited by 45
Dosing Frequency and Adherence to Antipsychotic Medications
Pfeiffer, P. N., Ganoczy, D., & Valenstein, M. M. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.10.1207 · Cited by 43
Community treatment orders: how ethical without experimental evidence?
Burns, T., & Dawson, J. (2009) · Psychological Medicine · doi:10.1017/s0033291709005352 · Cited by 41
Wong, M. M., Chen, E. Y. H., Lui, S. S. Y., & Tso, S. (2011) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.5.3.3 · Cited by 38
(2011) · PubMed · Cited by 38
Community treatment orders and antipsychotic long-acting injections
Lambert, T. J. R., SINGH, B. S., & Patel, M. X. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s57 · Cited by 37
Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey
Kim, E., Gupta, S., Bolge, S. C., Chen, C., Whitehead, R. E., & Bates, J. A. (2010) · Journal of Medical Economics · doi:10.3111/13696991003723023 · Cited by 35
Fanning, F., Foley, S. R., Lawlor, E., McWilliams, S., Jackson, D., Renwick, L., Sutton, M., Turner, N., Kinsella, A., Trimble, T. J., et al. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00333.x · Cited by 32
Talbott, J. A. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70720-5 · Cited by 32
Brain, C., Sameby, B., Allerby, K., Lindström, E., Eberhard, J., Burns, T., & Wærn, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.013 · Cited by 31
Self-citationBurton, A., Marougka, S., & Priebe, S. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001160 · Cited by 30
Increased use of antipsychotic long-acting injections with community treatment orders
Patel, M. X., Matonhodze, J., Baig, M. K., Gilleen, J., Boydell, J. E., Holloway, F. A., Taylor, D. M., SZMUKLER, G. I., Lambert, T. J. R., & David, A. S. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311407960 · Cited by 29
Helbling, J., Ajdacic‐Gross, V., Lauber, C., Weyermann, R., Burns, T., & Wulf Rössler, A. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-42 · Cited by 28
King, D., Knapp, M. R. J., Patel, A. K., Amaddeo, F., Tansella, M., Schene, A. H., Koeter, M. W. J., Angermeyer, M. C., & Becker, T. M. (2013) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796013000097 · Cited by 28
Gibson, T. B., Jing, Y., Kim, E., Bagalman, E., Wang, S., Whitehead, R. E., Tran, Q.-V., & Doshi, J. A. (2010) · PubMed · Cited by 28
Brook, M. G., Dale, A., Tomlinson, D., Waterworth, C., Daniels, D., & FORSTER, G. E. (2001) · AIDS Patient Care and STDs · doi:10.1089/108729101753145484 · Cited by 27
Burns, T. (2010) · The Psychiatrist · doi:10.1192/pb.bp.110.030254 · Cited by 26
Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports
Haddad, P. M., Hellewell, J. S. E., & Wieck, A. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500408 · Cited by 26
Self-citationLepage, M., Bodnar, M. D., Joober, R., & MALLA, A. K. (2010) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2010.00174.x · Cited by 22
Valimaki, M. A., Hätönen, H. M., & Adams, C. E. (2012) · JMIR Research Protocols · doi:10.2196/resprot.2136 · Cited by 17
Ballenger, J. C. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.08.020 · Cited by 17
Sector and functional models of consultant care: in-patient satisfaction with psychiatrists
Laugharne, R. A., & Pant, M. (2012) · The Psychiatrist · doi:10.1192/pb.bp.111.037333 · Cited by 14
Patel, U. B., Ni, Q., Clayton, C., Lam, P. C., & Parks, J. (2010) · Population Health Management · doi:10.1089/pop.2009.0053 · Cited by 8
Adverse effects and antipsychotic long-acting injections
Haddad, P. M., & Fleischhacker, W. W. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198729471.003.0003 · Cited by 8
Self-citationThe role of antipsychotic long-acting injections in current practice*
Haddad, P. M., Lambert, T. J. R., & Lauriello, J. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199586042.003.0011 · Cited by 3
Self-citation
Cited by
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationVelligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s124658 · Cited by 333
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Haddad, P. M., & Correll, C. U. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318781475 · Cited by 259
Self-citationHo, S. C., Chong, H. Y., Chaiyakunapruk, N., Tangiisuran, B., & Jacob, S. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.029 · Cited by 186
Metadata
- Authors
- Haddad, P., Brain, C., & Scott, J.
- Venue
- Patient Related Outcome Measures
- Publisher
- Informa UK Limited
- Published
- 2014-06
- Volume
- 5
- Pages
- 43
- ISSN
- 1179-271X (ISSN-L)
- OpenAlex
- W1986011584
- Cited by
- 585
- References
- 146
- FWCI
- 32.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.